223 related articles for article (PubMed ID: 31285150)
21. [Development of a radiomics signature to predict Ki-67 expression level in non-small cell lung cancer].
Gu Q; Feng Z; Liang Q; Li M; Wang W; Rong P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1216-1222. PubMed ID: 30643066
[TBL] [Abstract][Full Text] [Related]
22. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.
Fave X; Zhang L; Yang J; Mackin D; Balter P; Gomez D; Followill D; Jones AK; Stingo F; Liao Z; Mohan R; Court L
Sci Rep; 2017 Apr; 7(1):588. PubMed ID: 28373718
[TBL] [Abstract][Full Text] [Related]
23. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
[TBL] [Abstract][Full Text] [Related]
25. Decoding tumor stage by peritumoral and intratumoral radiomics in resectable esophageal squamous cell carcinoma.
Tan XZ; Ma R; Liu P; Xiao CH; Zhang HH; Yang F; Liang CH; Liu ZY
Abdom Radiol (NY); 2024 Jan; 49(1):301-311. PubMed ID: 37831168
[TBL] [Abstract][Full Text] [Related]
26. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
27. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
Ma Y; Li Q
Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
[TBL] [Abstract][Full Text] [Related]
28. Radiomics in predicting tumor molecular marker P63 for non-small cell lung cancer.
Gu Q; Feng Z; Hu X; Ma M; Mustafa Jumbe M; Yan H; Liu P; Rong P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Sep; 44(9):1055-1062. PubMed ID: 31645497
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
Yu W; Tang C; Hobbs BP; Li X; Koay EJ; Wistuba II; Sepesi B; Behrens C; Rodriguez Canales J; Parra Cuentas ER; Erasmus JJ; Court LE; Chang JY
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1090-1097. PubMed ID: 29246722
[TBL] [Abstract][Full Text] [Related]
30. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma.
Tan X; Ma Z; Yan L; Ye W; Liu Z; Liang C
Eur Radiol; 2019 Jan; 29(1):392-400. PubMed ID: 29922924
[TBL] [Abstract][Full Text] [Related]
31. Exploring technical issues in personalized medicine: NSCLC survival prediction by quantitative image analysis-usefulness of density correction of volumetric CT data.
Farchione A; Larici AR; Masciocchi C; Cicchetti G; Congedo MT; Franchi P; Gatta R; Lo Cicero S; Valentini V; Bonomo L; Manfredi R
Radiol Med; 2020 Jul; 125(7):625-635. PubMed ID: 32125637
[TBL] [Abstract][Full Text] [Related]
32. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
33. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
34. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
[TBL] [Abstract][Full Text] [Related]
35. Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC.
Hou S; Fan Y; Wang X; Su J; Ren M; Wu Y; Zhou J; Qu M; Luo Y; Jiang W
Acad Radiol; 2023 Jun; 30(6):1039-1046. PubMed ID: 35907759
[TBL] [Abstract][Full Text] [Related]
36. An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma.
Chen H; Liang M; Li X; Wu T; Zhang L; Liu X
Clin Radiol; 2020 Jul; 75(7):562.e11-562.e19. PubMed ID: 32307110
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer.
Tang X; Huang H; Du P; Wang L; Yin H; Xu X
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2247-2260. PubMed ID: 35430688
[TBL] [Abstract][Full Text] [Related]
38. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of MRI-based radiomics model to predict recurrence risk in patients with endometrial cancer: a multicenter study.
Lin Z; Wang T; Li Q; Bi Q; Wang Y; Luo Y; Feng F; Xiao M; Gu Y; Qiang J; Li H
Eur Radiol; 2023 Aug; 33(8):5814-5824. PubMed ID: 37171486
[TBL] [Abstract][Full Text] [Related]
40. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions.
Tunali I; Hall LO; Napel S; Cherezov D; Guvenis A; Gillies RJ; Schabath MB
Med Phys; 2019 Nov; 46(11):5075-5085. PubMed ID: 31494946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
